FDA Inspection 1204769 — BioCheck, Inc.
The FDA completed an inspection of BioCheck, Inc. on February 7, 2023 in South San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 7, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- South San Francisco, CA (United States)